Monitoring of low-molecular-weight heparins in cardiovascular disease
- 1 September 1998
- journal article
- review article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 82 (5) , 33L-36L
- https://doi.org/10.1016/s0002-9149(98)00111-8
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Low molecular weight heparins: a developmental perspectiveExpert Opinion on Investigational Drugs, 1997
- Prolonged Antithrombin Activity of Low-Molecular-Weight HeparinsCirculation, 1995
- LOW MOLECULAR WEIGHT HEPARIN(S)British Journal of Haematology, 1995
- Tissue factor pathway inhibitorCurrent Opinion in Lipidology, 1994
- Laboratory monitoring of thromboprophylaxis with low molecular weight and standard heparinThrombosis Research, 1992
- Low molecular weight heparinBlood, 1992
- Regulation of coagulation by a multivalent Kunitz-type inhibitorBiochemistry, 1990
- In vitro effect on heptest® of low molecular weight heparin fractions and preparations with various anti-IIa and anti-Xa activitiesThrombosis Research, 1990
- Biological Activrty and Safety of the Subcutaneous Administration of High Doses of Low Molecular Weight Heparin for 8 Days in Human VolunteersThrombosis and Haemostasis, 1989
- Anticoagulant activities of heparin oligosaccharides and their neutralization by platelet factor 4Biochemical Journal, 1984